News
MDT
83.60
+0.29%
0.24
Medtronic Third Quarter 2024 Earnings: Beats Expectations
Medtronic's third quarter revenues exceeded analyst estimates by 1.7%. The company's shares are down 2.4% from a week ago. Revenue is forecast to grow 4.3% in the next 3 years. Simply Wall St looks at the company's balance sheet.
Simply Wall St · 1d ago
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
These are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Amgen Inc., Medtronic plc and AbbVie are among the companies with the highest dividend yields. Benzinga readers can review the latest analyst takes on their favorite stocks.
Benzinga · 2d ago
Medtronic accuses Axonics of patent infringement, files ITC complaint
Healthcare Medtronic accuses Axonics of patent infringement, files ITC complaint. Axonics says it intends to "vigorously" defend itself against the accusations. The medical device company claims Axonics infringed upon two Medtronics implantable device patents. Axionics markets an implantable neurostimulator system for incontinence.
Seeking Alpha · 3d ago
Axonics Responds To ITC Action By Medtronic; CEO Says "We Believe Medtronic's Claims Are Designed To Stifle Competition, Limit Patient And Physician Choice, And Protect The Incumbent's Market Position"
Medtronic has filed a complaint against Axonics. The complaint alleges that Axonics infringes two Medtronic patents. Axonics says the claims are designed to stifle competition and protect the incumbent's market position in sacral neuromodulation therapy. The company says it will defend itself vigorously.
Benzinga · 3d ago
Medtronic Files Complaint Against Axonics With US ITC For Two Patent Infringements
NASDAQ · 3d ago
Medtronic files ITC action against Axonics to stop unauthorized use of Medtronic innovations
Medtronic filed a complaint with the U.S. International Trade Commission to block Axonics from improperly importing and selling products that infringe two Medtronic patents. The products infringe on two Med tronic patents related to MRI compatibility of implantable medical devices. Axonics is accused of improperly competing in the market.
PR Newswire · 3d ago
Stifel Nicolaus Remains a Buy on Medtronic (MDT)
TipRanks · 3d ago
Medtronic (MDT) Gets a Buy from Wells Fargo
TipRanks · 3d ago
Top Analyst Reports for Eli Lilly, Procter & Gamble & Morgan Stanley
NASDAQ · 5d ago
Globus Medical Q4: Greater Dis-Synergies Hold Back The Stock
Shares of Globus Medical, Inc. Have seen a decent recovery, but the 2024 earnings guidance is a touch light. The company's deal with NuVasive was expected to bring in synergies and improve earnings per share, but dis-synergies are limiting growth. The stock remains cheap based on sales multiples, but real earnings execution is needed.
Seeking Alpha · 5d ago
Notable ETF Inflow Detected - IVE, T, ELV, MDT
NASDAQ · 5d ago
Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction In 24-Hour Ambulatory Systolic Blood Pressure In Hypertensive Pacemaker Patients Treated With AVIM Therapy For Over 3 Years
Orchestra BioMed Holdings, Inc. Presented long-term blood pressure data at the Innovation in Cardiovascular Interventions meeting. Long-term study of AVIM therapy in hypertensive pacemaker patients shows significant reduction in 24-hour ambulatory systolic blood pressure at average of 3.6 years. Orchestra BioMed is actively enrolling patients in the BACKBEAT pivotal study of the therapy.
Benzinga · 6d ago
Weekly Report: what happened at MDT last week (0219-0223)?
Weekly Report · 6d ago
Should You Pick Boston Scientific Stock After A Solid Q4 And 13% Uptick This Year?
NASDAQ · 6d ago
Needham sees orthopedics market slowing; favors Enovis, Paragon 28
Healthcare Needham sees orthopedics market slowing; favors Enovis, Paragon 28. Needham says it expects growth in the orthopedic device market to slow to 4% to 5% for 2024 and beyond. The investment bank says it sees growth in 2023 at the highest rate in over ten years.
Seeking Alpha · 02/25 23:50
If You Invested $10,000 in Medtronic in 2019, This Is How Much You Would Have Today
Medtronic is a medical device specialist that has been struggling since the outbreak of COVID-19. The company is one of the largest in the world and is making a push into the diabetes care market. Medtronic stock has been an underperformer in the past five years. The stock is a top pick for income seekers looking for a comeback.
The Motley Fool · 02/25 19:37
Medtronic: Its Recent Beat Proves That It Continues To Be A Rock
Medtronic plc (MDT) reported Q3 2024 earnings beat estimates, affirming my "strong buy" recommendation. Previous analysis suggested a fair price of $137.6 for the stock. The most important market for Medtronic is cardiovascular, but other segments can outperform.
Seeking Alpha · 02/25 14:38
The Best Of Times And The Worst Of Times: A Tale Of Two Stock Markets
Seeking Alpha · 02/24 13:20
Polen International Growth Q4 2023 Commentary
Polen International Growth Composite Portfolio outpaced the MSCI ACWI ex-USA Index in the fourth quarter of 2023. The consensus view that 2023 would bring a global recession proved wrong. In our view, valuations of many of the companies in the portfolio are fair.
Seeking Alpha · 02/23 10:40
More
Webull provides a variety of real-time MDT stock news. You can receive the latest news about Medtronic through multiple platforms. This information may help you make smarter investment decisions.
About MDT
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.